Skip to content
akaturk Academic measurement
Articles 8 YÖKSİS 8 · OpenAlex 0 Total citations 83 h-index 4 · OpenAlex Q1 articles 2 Scopus · WoS Q1 3 Best field rank #112 / 242 Side field · top 46.3% Co-authors 17 3 Turkish institutions
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Kimya
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 8
YÖKSİS8 OpenAlex0
Projects 4
Books 0
Proceedings 4

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 8
h-index 4 Percentile in Türkiye: 53 #1,308 of 2,184 at their university by h-index
i10-index
3
Total citations
83
Top 39% in Türkiye
Per article
10.4
FWCI
1.98
1.00 = world average
World top 1%
0
World top 10%
2

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
17
With an akaturk profile
9
Turkish institutions
3
Co-authored works
%100

Academic co-authors 9

  1. GÖKÇEN EREN Profesör · Gazi Üniversitesi same university 7
  2. FİLİZ BAKAR ATEŞ Profesör · Ankara Üniversitesi 5
  3. MAHMUT GÖZELLE Doktor Öğretim Üyesi · Gazi Üniversitesi same university 5
  4. YEŞİM ÖZKAN Profesör · Gazi Üniversitesi same university 5
  5. AHMET BUĞRA AKSEL Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 3
  6. ERVA ÖZKAN Doktor Öğretim Üyesi · Ankara Medipol Üniversitesi 3
  7. HABİBE BEYZA GÜNİNDİ Araştırma Görevlisi · Gazi Üniversitesi same university 2
  8. FİKRİYE ÖZGENCİL Araştırma Görevlisi · Gazi Üniversitesi same university 1
  9. YASEMİN DÜNDAR Profesör · Gazi Üniversitesi same university 1

National collaboration 3 institutions

Within own university7 joint works · Gazi Üniversitesi

  1. Ankara Üniversitesi 5 works · 1 academics
  2. Ankara Medipol Üniversitesi 3 works · 1 academics
  3. Karadeniz Teknik Üniversitesi 3 works · 1 academics

Other co-authors (incl. international) 8

ALBERTO MASSAROTTI 3ALESSIA RAUCCIANTONELLO MAICLEMENS ZWERGELRENGÜL ATALAYROBERTO CIRILLISEMİH YAĞCISERGIO VALENTE

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Index quartiles

?
Scopus (SJR) 8
  • Q1 2 %25.0
  • Q2 5 %62.5
  • Q3 1 %12.5
  • Q4 0 %0.0
WoS (JCR) 8
  • Q1 3 %37.5
  • Q2 4 %50.0
  • Q3 1 %12.5
  • Q4 0 %0.0
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%2
Avg · n 8 %73.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 8

WoS (JCR)

  • YÖKSİS rows 8

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

8articles

Journals with publications

6 journals

Narrow down

Scopus (SJR)
Q12 Q25 Q31 Q40
WoS (JCR)
Q13 Q24 Q31 Q40
TR Index
0articles

Article list

  1. 2026 Probing Chiral Recognition on Amylose Tris(3,5‐Dimethylphenylcarbamate) Using Cinnamyl 2‐Aminoanilides: The Subtle Impact of Aliphatic Substituents ELECTROPHORESIS DOI 10.1002/elps.70109 YÖKSİS SJR Q3 JCR Q3 OpenAlex 34.5%
  2. 2026 Structure‐Guided Optimization and Biological Validation of 1,3,4‐Thiadiazole‐Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions Drug Development Research DOI 10.1002/ddr.70256 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 96.4%
  3. 2024 2‐(Methyl(phenyl)amino)‐N‐(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition Drug Development Research DOI 10.1002/ddr.22224 YÖKSİS SJR Q2 JCR Q1 OpenAlex 72.1%
  4. 2024 Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy Bioorganic Chemistry DOI 10.1016/j.bioorg.2023.107038 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.3%
  5. 2024 Symmetrical 2,7‐disubstituted 9H‐fluoren‐9‐one as a novel and promising scaffold for selective targeting of SIRT2 ARCHIV DER PHARMAZIE DOI 10.1002/ardp.202400661 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.3%
  6. 2022 Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105746 YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.1%
  7. 2021 Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT BIOORGANIC & MEDICINAL CHEMISTRY DOI 10.1016/j.bmc.2020.115961 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.3%
  8. 2019 Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors JOURNAL OF MOLECULAR GRAPHICS & MODELLING DOI 10.1016/j.jmgm.2019.02.014 YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.0%

← Back to academicians